XIANGLING LI – Trademark Portfolio

Entity Type: 01

XIANGLING LI holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 4 (Lubricants & Fuels) — 1 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include WOSUME and YEEDOD. The owner is based in Guangzhou, Guangdong,.

No.5, Hongcitang Street, Zhongcun Town,

Panyu District,

Guangzhou, Guangdong, 510000 , CN

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

WOSUME
WOSUME
Registered 2022
YEEDOD
YEEDOD
Registered 2022

Trademark Classifications

XIANGLING LI's trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

4
Lubricants & Fuels (1 filing)

Industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does XIANGLING LI have?

XIANGLING LI has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does XIANGLING LI file in?

XIANGLING LI files trademarks across 2 Nice Classification classes. The most active classes are Class 4 (Lubricants & Fuels), Class 10 (Medical Apparatus). Class 4 covers industrial oils and greases; lubricants; dust absorbing, wetting and binding compositions.

What are XIANGLING LI's most well-known trademarks?

XIANGLING LI's registered trademark portfolio includes well-known marks such as WOSUME and YEEDOD. These are among 2 currently registered trademarks in the portfolio.

What is XIANGLING LI's trademark registration success rate?

XIANGLING LI has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.